Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected] - Fukuoka,M.; Yano,S.; Giaccone,G. (J Clin Oncol, 2003)